# FDA Inspection 1034231 - Macfarlan Smith Limited - November 10, 2017

Source: https://www.keypedia.com/records/fda_inspections/macfarlan-smith-limited/7199b4cb-7c2e-48c1-9ea4-147108dbc5eb
Source feed: FDA_Inspections

> FDA Inspection 1034231 for Macfarlan Smith Limited on November 10, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1034231
- Company Name: Macfarlan Smith Limited
- Inspection Date: 2017-11-10
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1202311 - 2021-11-29](https://www.keypedia.com/records/fda_inspections/macfarlan-smith-limited/34a712ea-fb7c-41da-b44c-484afdc3136d)
- [FDA Inspection 944898 - 2015-09-04](https://www.keypedia.com/records/fda_inspections/macfarlan-smith-limited/ed52474f-cfd2-4f08-874d-d09b7dffc530)
- [FDA Inspection 780134 - 2012-04-13](https://www.keypedia.com/records/fda_inspections/macfarlan-smith-limited/f7ab57de-2875-4783-936f-bea86fd59e56)

Company: https://www.keypedia.com/companies/macfarlan-smith-limited/3be742c2-20c9-4343-bfc8-2807e16fe247

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c